Free Trial

Esperion Therapeutics (ESPR) Insider Trading & Ownership

Esperion Therapeutics logo
$1.46 -0.04 (-2.33%)
As of 12:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Esperion Therapeutics (NASDAQ:ESPR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$5,779.25
Get ESPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ESPR Insider Buying and Selling by Quarter

Remove Ads

Esperion Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2025Benjamin HalladayCFOSell3,535$1.48$5,231.80  
2/19/2025Benjamin HalladayCFOSell11$1.86$20.46  
1/17/2025Benjamin HalladayCFOSell9$2.27$20.43  
10/17/2024Eric WarrenInsiderSell107$2.12$226.84  
7/17/2024Eric WarrenInsiderSell108$2.59$279.72  
(Data available from 1/1/2013 forward)

ESPR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Esperion Therapeutics includes Benjamin Halladay, Benjamin Looker, Eric Warren, J Martin Carroll, Joanne M Foody, and Sheldon L Koenig. Learn more on insiders at ESPR.

1.00% of Esperion Therapeutics stock is owned by insiders. Learn more on ESPR's insider holdings.

The following insiders have purchased ESPR shares in the last 24 months: J Martin Carroll ($12,529.41), and Sheldon L Koenig ($25,200.00).

Insiders have purchased a total of 28,409 ESPR shares in the last 24 months for a total of $37,729.41 bought.

The following insiders have sold ESPR shares in the last 24 months: Benjamin Halladay ($5,272.69), Benjamin Looker ($1,638.30), and Eric Warren ($3,338.59).

Insiders have sold a total of 7,088 Esperion Therapeutics shares in the last 24 months for a total of $10,249.58 sold.

Esperion Therapeutics Key Executives

  • Mr. Sheldon L. Koenig (Age 58)
    President, CEO & Director
    Compensation: $1.28M
  • Mr. Eric J. Warren R.Ph. (Age 52)
    Chief Commercial Officer
    Compensation: $718.86k
  • Mr. Benjamin Halladay M.B.A. (Age 38)
    Chief Financial Officer
    3 recent trades
  • Mr. Glenn P. Brame (Age 66)
    Chief Technical Operations Officer
  • Mr. Benjamin O. Looker J.D. (Age 42)
    General Counsel & Corporate Secretary
    Compensation: $550.35k
  • Tiffany Aldrich M.B.A.
    Associate Director of Corporate Communications
  • Ms. Betty Jean Swartz
    Chief Business Officer


This page (NASDAQ:ESPR) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners